These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37298200)

  • 21. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W; Chen YH; Liu H; Qu HD
    Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.
    Lv E; Deng J; Yu Y; Wang Y; Gong X; Jia J; Wang X
    Free Radic Res; 2015; 49(11):1296-307. PubMed ID: 26118717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson's disease.
    Leem YH; Kim DY; Park JE; Kim HS
    Sci Rep; 2023 May; 13(1):8783. PubMed ID: 37258791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
    Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
    Bioorg Med Chem; 2013 Sep; 21(17):5532-47. PubMed ID: 23810671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
    Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q
    Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feruloylated oligosaccharides ameliorate MPTP-induced neurotoxicity in mice by activating ERK/CREB/BDNF/TrkB signalling pathway.
    Ding Y; Zhou M; Zheng R; Ma R; Deng J; Hao WZ; Wang L; Zhang JC; Ho CT; Huang JQ
    Phytomedicine; 2023 Jan; 108():154512. PubMed ID: 36288652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
    Li Q; Shen C; Liu Z; Ma Y; Wang J; Dong H; Zhang X; Wang Z; Yu M; Ci L; Sun R; Shen R; Fei J; Huang F
    Cell Prolif; 2021 Aug; 54(8):e13094. PubMed ID: 34312932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
    Sampath C; Kalpana R; Ansah T; Charlton C; Hale A; Channon KM; Srinivasan S; Gangula PR
    Dig Dis Sci; 2019 Dec; 64(12):3502-3517. PubMed ID: 31187328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
    Shi L; Jia L; Wang Y; Xiu M; Xie J
    Neurochem Res; 2023 Jun; 48(6):1707-1715. PubMed ID: 36602724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
    Santoro M; Maetzler W; Stathakos P; Martin HL; Hobert MA; Rattay TW; Gasser T; Forrester JV; Berg D; Tracey KJ; Riedel G; Teismann P
    Neurobiol Dis; 2016 Jul; 91():59-68. PubMed ID: 26921471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease.
    Ardah MT; Bharathan G; Kitada T; Haque ME
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.
    Liu N; Bai L; Lu Z; Gu R; Zhao D; Yan F; Bai J
    J Neuroinflammation; 2022 Jan; 19(1):26. PubMed ID: 35093118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
    Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
    Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy.
    Liu X; Liu W; Wang C; Chen Y; Liu P; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Physiol Behav; 2021 Oct; 239():113510. PubMed ID: 34181930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.